ArticleCancer gene therapy2021

miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer.

Francesco Palma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.